Amgen, Inc. (AMGN)
340.00
-2.57
(-0.75%)
USD |
NASDAQ |
Apr 07, 16:00
342.49
+2.49
(+0.73%)
After-Hours: 20:00
Amgen Cash from Investing (TTM) : -1.943B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Biogen, Inc. | -1.371B |
| Gilead Sciences, Inc. | -4.793B |
| Johnson & Johnson | -23.59B |
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Moderna, Inc. | 1.946B |